文献速递妇科

子宫癌术后管理中调强放疗使用模式的分析

Patterns of care of IMRT usage in postoperative management of uterine cancer.
PubMed 文献 · Gynecol Oncol · 2016-11-22

基于美国国家癌症数据库,分析2004至2012年接受子宫切除术后外照射放疗的子宫内膜腺癌女性,IMRT使用率从1.9%升至32.4%(p<0.001),2012年较2004年调整OR为24.90(95%CI 15.24-40.67),但IMRT与生存改善无显著关联(HR 0.86,95%CI 0.73-1.01,p=0.06),且存在社会经济与种族差异。

要点

  • IMRT使用率从2004年1.9%增至2012年32.4%(p<0.001)。
  • 2012年较2004年IMRT使用调整OR为24.90(95%CI 15.24-40.67)。
  • 黑人种族较白人IMRT使用OR为0.60(95%CI 0.44-0.81,p=0.001)。

核心结论

  • 在这项基于医院登记的数据中,2004至2012年间子宫癌术后放疗的IMRT使用率显著增加,但未带来显著生存改善;IMRT使用分配存在社会经济和种族差异。

研究设计与样本

  • 查询美国国家癌症数据库,纳入2004至2012年接受子宫切除术后外照射放疗的子宫内膜腺癌女性,共7839例。
  • 使用描述性统计和卡方检验分析IMRT使用情况,比较IMRT与三维适形放疗的总生存,采用多变量逻辑回归和多变量Cox回归识别影响IMRT使用和生存改善的协变量。

主要发现

  • IMRT使用率从2004年1.9%增至2012年32.4%(p<0.001)。
  • 2012年较2004年IMRT使用的调整OR为24.90(95%CI 15.24-40.67,p<0.001)。
  • 多变量分析中除年份外,IMRT使用的预测因素还包括阳性淋巴结、较高剂量、私人保险和高收入。
  • 黑人种族较白人IMRT使用OR为0.60(95%CI 0.44-0.81,p=0.001)。
  • IMRT与生存改善无显著关联(HR 0.86,95%CI 0.73-1.01,p=0.06);研究组内黑人种族和阳性淋巴结与生存降低相关,私人保险和高收入与生存改善相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze the patterns of care regarding intensity modulated radiation therapy (IMRT) usage in the postoperative management of uterine cancer. METHODS: The National Cancer Database was queried to identify women with endometrial adenocarcinoma who underwent hysterectomy followed by external beam radiation between 2004-2012. Descriptive statistics were used to analyze IMRT usage with comparison via the Chi Square test. Overall survival was also compared between IMRT and three dimensional conformal radiation therapy. Multivariable logistic regression and multivariable Cox Regression were used to identify covariables that impact IMRT usage and improved survival respectively. RESULTS: 7839 women were included in this study. IMRT utilization increased from 1.9% in 2004 to 32.4% in 2012 (p<0.001). The adjusted odds ratio (OR) for IMRT in 2012 compared with 2004 was 24.90, 95% CI 15.24-40.67 (p<0.001). Aside from year, other predictors of IMRT usage on multivariate analysis were positive nodes, higher dose, private insurance and higher income. Black race was associated with lower IMRT usage compared to Whites with an OR of 0.60, 95% CI 0.44-0.81 (p=0.001). IMRT was not associated with significantly increased survival (HR 0.86, 95% CI 0.73-1.01, p=0.06). Black race and positive nodes were associated with decreased survival within the group studied whereas private insurance and higher income were associated with improved survival. CONCLUSIONS: In this hospital-based registry, IMRT has significantly increased in utilization for postoperative radiation in uterine cancer between 2004-2012 although not resulting in significantly improved survival. Socioeconomic and racial disparities exist in the allocation of IMRT usage.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Osborn V, Schwartz D, Lee YC, et al. Patterns of care of IMRT usage in postoperative management of uterine cancer. Gynecol Oncol. 2016. PMID: 27887805. doi:10.1016/j.ygyno.2016.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。